Brazil Neurology Devices Market: Market Size & Forecast 2026

The Brazil Neurology Devices Market encompasses equipment used to diagnose, monitor, and treat disorders of the brain, spine, and peripheral nervous system, including neuroimaging systems, neurostimulation devices, neurosurgical instruments, and cerebrospinal fluid management tools. Brazil is the largest medical device market in Latin America, supported by a universal public health system (SUS) and a sizeable private hospital network. Market activity is concentrated around São Paulo, Rio de Janeiro, and other major metropolitan areas where tertiary neuroscience centers are located.

• •Estimated 2025 market value: USD 678.88 billion (Latin America regional figure)
• •Forecast CAGR of 5.94% through the next decade
• •Demand is anchored by SUS procurement, private hospital investment, and growing imports of high-end devices

Demographic aging is a primary structural driver, as Brazil's population over 60 is growing rapidly and carries a higher burden of stroke, Parkinson's disease, Alzheimer's disease, and epilepsy. Rising disposable income, expansion of private health insurance, and incremental incorporation of neurology procedures into SUS coverage are widening patient access. Technology adoption, including robot-assisted neurosurgery, AI-assisted imaging, and wearable neuro-monitoring, is also pulling capital investment into the segment.

• •Rising incidence of stroke, dementia, and movement disorders among older adults
• •Public and private reimbursement reforms improving patient access to advanced neurology procedures
• •Growing clinician demand for minimally invasive and image-guided neurosurgical tools

The market is commonly segmented by device type (neurostimulation, interventional neurology, neurosurgical devices, cerebrospinal fluid management, and neuroimaging) and by end user (hospitals, ambulatory surgery centers, and specialty neurology clinics). Within Latin America, Brazil accounts for the largest share, followed by Mexico, Argentina, Chile, and Colombia, with cross-border medical travel further concentrating complex cases in Brazilian centers. The South and Southeast regions of Brazil dominate equipment adoption due to higher per capita income and the density of academic hospitals.

• •Hospitals represent the largest end-user segment, with growth in ambulatory neurosurgery centers
• •São Paulo, Rio de Janeiro, and Belo Horizonte are leading adoption hubs
• •Brazilian market growth outpaces the Latin American average on a percentage basis

What are the recent trends and outlook?

Near-term trends point to broader deployment of minimally invasive stroke intervention (mechanical thrombectomy), spinal cord and deep brain stimulation, and AI-enabled neuroimaging. Local production of selected devices under Brazilian government industrial policy is expected to gradually reduce import dependence for lower-complexity products. Over the forecast horizon, the market is likely to see continued double-digit growth in specific high-value sub-segments such as neurostimulation and interventional neuroradiology, even as the headline growth rate moderates in line with broader medical device trends globally.

• •AI-assisted diagnostics and image-guided neurosurgery are key technology trajectories
• •Increasing FDA and ANVISA approvals for next-generation neurostimulation and thrombectomy devices
• •Long-term outlook remains positive, supported by demographic demand and Latin America's overall medical device expansion toward USD 1.2 trillion by 2035